Eight weeks of mindfulness worked as well as an antidepressant for anxiety
In the first head-to-head trial of its kind, a mindfulness course reduced anxiety as much as escitalopram, a widely prescribed drug, with far fewer side effects.
Anxiety disorders are among the most common mental health conditions. Treatment usually means medication, talking therapy or both. A team at Georgetown University Medical Center compared a mindfulness course directly with one of the most widely used drugs.
Elizabeth Hoge and colleagues published the trial in JAMA Psychiatry in 2023. They randomised 276 adults with a diagnosed anxiety disorder, including generalised anxiety, social anxiety, panic disorder and agoraphobia, to one of two treatments for eight weeks:
- mindfulness-based stress reduction (MBSR): a weekly 2.5-hour class, a one-day retreat and about 45 minutes of daily practice at home,
- escitalopram, a selective serotonin reuptake inhibitor (SSRI), at a standard dose.
What they found
- Anxiety severity, rated by clinicians, fell by a similar amount in both groups. The mindfulness course met the trial's test for being no worse than the drug.
- Adverse events were reported by 15.4 percent of the mindfulness group and 78.6 percent of the escitalopram group.
- Common side effects of the drug included sleep problems, nausea and fatigue.
What it means
For people with anxiety who prefer not to take medication, or who have side effects, a structured mindfulness course is a credible alternative. It requires time and regular practice, which is its main cost.
How to apply it
- Look for an accredited MBSR course, delivered in person or online, rather than an app alone. The trial used the full eight-week programme.
- Practise daily, even on days without anxiety. The benefit builds with repetition.
- Do not stop prescribed medication without talking to your doctor.
- If anxiety interferes with work, sleep or relationships, seek professional assessment first.
A note on the evidence
About three quarters of participants were women, and the trial lasted eight weeks, so long-term results and effects in men specifically are less clear. Participants knew which treatment they were receiving.
Sources
- Hoge EA et al. Mindfulness-based stress reduction vs escitalopram for the treatment of adults with anxiety disorders: a randomized clinical trial. JAMA Psychiatry, 2023. doi:10.1001/jamapsychiatry.2022.3679




